Biology Reference
In-Depth Information
158. Yang S, Irani K, HeffronSE, Jurnak F,Meyskens Jr FL. Alterations in
the expression of the apurinic/apyrimidinic endonuclease-1/
redox factor-1 (APE/Ref-1) in humanmelanoma and identification
of the therapeutic potential of resveratrol as an APE/Ref-1 inhib-
itor. Mol Cancer Ther 2005;
acid-induced differentiation and apoptosis. Exp Hematol 2010;
38
88.
161. Zou GM, Maitra A. Small-molecule inhibitor of the AP endonu-
clease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and
migration. Mol Cancer Ther 2008;
(12):1178
e
35.
159. Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, Maitra A.
The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of
tumor endothelium and endothelial progenitor cells: therapeutic
implications in tumor angiogenesis. J Cell Physiol 2009;
(12):1923
21.
162. Nyland RL, Luo M, Kelley MR, Borch RF. Design and synthesis of
novel quinone inhibitors targeted to the redox function of apur-
inic/apyrimidinic endonuclease 1/redox enhancing factor-1
(Ape1/ref-1). J Med Chem 2010;
(7):2012
4
e
7
e
(1):
10.
163. Kelley MR, Luo M, Reed A, et al. Functional analysis of novel
analogues of E3330 that block the redox signaling activity of the
multifunctional AP endonuclease/redox signaling enzyme
APE1/Ref-1. Antioxid Redox Signal 2011;
(3):1200
219
53
e
18.
160. Fishel ML, Colvin ES, Luo M, Kelley MR, Robertson KA.
Inhibition of the redox function of APE1/Ref-1 in myeloid
leukemia cell lines results in a hypersensitive response to retinoic
209
e
(8):1387
401.
14
e
Search WWH ::




Custom Search